These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients. Lorber A; Cohen RL; Chang CC; Anderson HE Arthritis Rheum; 1968 Apr; 11(2):170-7. PubMed ID: 5645729 [No Abstract] [Full Text] [Related]
3. [Significance of serum gold level determination during chrysotherapy]. Bahous I; Müller W Verh Dtsch Ges Rheumatol; 1976; 4():395-400. PubMed ID: 997815 [No Abstract] [Full Text] [Related]
4. [In vivo transport of gold in chrysotherapy of rheumatoid arthritis]. Yamanaka K; Yamada O; Yamazaki S Rinsho Byori; 1971 Jan; 19(1):68-73. PubMed ID: 5103833 [No Abstract] [Full Text] [Related]
5. [The significance of gold serum level determinations during chrysotherapy in rheumatoid arthritis (author's transl)]. Bahous I; Müller W; Stojan B Med Klin; 1975 Sep; 70(38):1516-21. PubMed ID: 810649 [TBL] [Abstract][Full Text] [Related]
7. Gold distribution in whole blood during chrysotherapy. Smith PM; Smith EM; Gottlieb NL J Lab Clin Med; 1973 Dec; 82(6):930-7. PubMed ID: 4202278 [No Abstract] [Full Text] [Related]
8. A unified method for the determination of gold in biological fluids by flameless atomic absorption spectroscopy. Pedersen SM; Graabaek PM Scand J Clin Lab Invest; 1977 Feb; 37(1):91-4. PubMed ID: 616034 [TBL] [Abstract][Full Text] [Related]
9. [Significance of serum gold levels during chrysotherapy in chronic polyarthritis (proceedings)]. Bahous I; Müller W Z Rheumatol; 1976; 35 Suppl 4():suppl 395-400. PubMed ID: 983398 [No Abstract] [Full Text] [Related]
10. [Can complications with gold therapy be anticipated?]. Králík V Fysiatr Revmatol Vestn; 1968 Apr; 46(2):93-7. PubMed ID: 5690307 [No Abstract] [Full Text] [Related]
11. Serum gold levels during chrysotherapy with relation to urinary and fecal excretion. Harth M Clin Pharmacol Ther; 1974 Apr; 15(4):354-60. PubMed ID: 4206926 [No Abstract] [Full Text] [Related]
13. Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy. Gottlieb NL; Smith PM; Smith EM Arthritis Rheum; 1972; 15(1):16-22. PubMed ID: 5059639 [No Abstract] [Full Text] [Related]
14. [Pharmacodynamic examination of patients treated with gold preparations]. Sorensen SS Nord Med; 1970 Nov; 84(47):1508. PubMed ID: 5494985 [No Abstract] [Full Text] [Related]
15. Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination. van Riel PL; Gribnau FW; van de Putte LB J Rheumatol; 1983 Aug; 10(4):574-8. PubMed ID: 6413685 [TBL] [Abstract][Full Text] [Related]
16. [Study of lysozyme in the blood, urine and synovial fluid in different stages of rheumatoid polyarthritis and under the influence of therapy]. Georgesco C; Serban M; Gheorghiu M Med Interne; 1981; 19(1):51-4. PubMed ID: 7233047 [No Abstract] [Full Text] [Related]
17. Chrysotherapy: pharmacological and clinical correlates. Lorber A; Simon TM; Leeb J; Carroll PE J Rheumatol; 1975 Dec; 2(4):401-10. PubMed ID: 1206672 [TBL] [Abstract][Full Text] [Related]